UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Gotham Asset Management LLC

Gotham Asset Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 18,741 shares of the healthcare conglomerate's stock after purchasing an additional 1,980 shares during the quarter. Gotham Asset Management LLC's holdings in UnitedHealth Group were worth $9,480,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of UNH. Czech National Bank grew its holdings in shares of UnitedHealth Group by 6.1% in the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock worth $100,937,000 after acquiring an additional 11,426 shares during the last quarter. Aprio Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 15.9% in the 4th quarter. Aprio Wealth Management LLC now owns 1,337 shares of the healthcare conglomerate's stock worth $676,000 after acquiring an additional 183 shares during the last quarter. Matrix Trust Co grew its holdings in shares of UnitedHealth Group by 6.6% in the 4th quarter. Matrix Trust Co now owns 3,634 shares of the healthcare conglomerate's stock worth $1,838,000 after acquiring an additional 225 shares during the last quarter. Winthrop Advisory Group LLC grew its holdings in shares of UnitedHealth Group by 2.4% in the 4th quarter. Winthrop Advisory Group LLC now owns 1,301 shares of the healthcare conglomerate's stock worth $658,000 after acquiring an additional 31 shares during the last quarter. Finally, Fiduciary Alliance LLC grew its holdings in shares of UnitedHealth Group by 260.7% in the 4th quarter. Fiduciary Alliance LLC now owns 9,893 shares of the healthcare conglomerate's stock worth $5,005,000 after acquiring an additional 7,150 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $378.42 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $376.84 and a fifty-two week high of $630.73. The business has a 50-day moving average of $486.06 and a two-hundred day moving average of $520.74. The stock has a market capitalization of $343.28 billion, a P/E ratio of 24.41, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.22%. UnitedHealth Group's payout ratio is presently 35.18%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on UNH shares. Barclays decreased their target price on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Morgan Stanley decreased their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Robert W. Baird decreased their target price on UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Finally, KeyCorp decreased their target price on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Four equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.